Concepedia

Daniel Rohle

DR

6

Publications

2.7K

Citations

6

H-Index

2010

Active since

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

University of Pennsylvania

Daniel Rohle is an author at Cornell University specializing in tumor heterogeneity, tumor biology, and high-grade gliomas.

ORCID

Top concepts

Publications per year

2010–2022

6

Publications

6

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

Şevin Turcan, Daniel Rohle, Anuj Goenka et al. · Nature · 2012 · 1.9K citations · Full text

, , +11

Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

Igor Vivanco, H. Ian Robins, Daniel Rohle et al. · Cancer Discovery · 2012 · 336 citations · Full text

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

Sriram Venneti, Mark Dunphy, Hanwen Zhang et al. · Science Translational Medicine · 2015 · 303 citations · Full text

The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation

Igor Vivanco, Daniel Rohle, Matthias Versele et al. · Proceedings of the National Academy of Sciences · 2010 · 103 citations · Full text

EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer

Barbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument‐Bromage et al. · Nature Communications · 2017 · 35 citations · Full text

Rows per page

1–5 of 6